Literature DB >> 11791495

Pathophysiology of ischemic nephropathy.

L Lerman1, S C Textor.   

Abstract

Loss of renal function beyond a renal vascular lesion presents a complex challenge to clinicians. This article summarizes current understanding of critical vascular lesions to the kidney and putative mechanisms by which loss of perfusion activates fibrogenic mechanisms in the kidney. The authors emphasize alterations in vasoactive pathways, including disturbed oxidative stress, activation of endothelin, and reduced nitric oxide, which modulate cytokines and inflammatory mediators within the renal parenchyma. Improved understanding of these mechanisms is essential in preventing irreversible interstitial fibrosis and restoring renal perfusion.

Entities:  

Mesh:

Year:  2001        PMID: 11791495     DOI: 10.1016/s0094-0143(01)80034-3

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  23 in total

1.  Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: clinical and histopathological correlates.

Authors:  Mira T Keddis; Vesna D Garovic; Kent R Bailey; Christina M Wood; Yassaman Raissian; Joseph P Grande
Journal:  Nephrol Dial Transplant       Date:  2010-05-25       Impact factor: 5.992

Review 2.  Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease?

Authors:  Ahmed Saad; Sandra M Herrmann; Stephen C Textor
Journal:  Physiology (Bethesda)       Date:  2015-05

3.  Endothelial outgrowth cells shift macrophage phenotype and improve kidney viability in swine renal artery stenosis.

Authors:  Alfonso Eirin; Xiang-Yang Zhu; Zilun Li; Behzad Ebrahimi; Xin Zhang; Hui Tang; Michael J Korsmo; Alejandro R Chade; Joseph P Grande; Christopher J Ward; Robert D Simari; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02-21       Impact factor: 8.311

4.  The effect of thymoquinone on the renal functions following ischemia-reperfusion injury in the rat.

Authors:  Fayez T Hammad; Loay Lubbad
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-12-25

5.  Hydrogen-rich saline solution attenuates renal ischemia-reperfusion injury.

Authors:  Chihiro Shingu; Hironori Koga; Satoshi Hagiwara; Shigekiyo Matsumoto; Koji Goto; Isao Yokoi; Takayuki Noguchi
Journal:  J Anesth       Date:  2010-05-18       Impact factor: 2.078

6.  Low-Energy Shockwave Therapy Improves Ischemic Kidney Microcirculation.

Authors:  Xin Zhang; James D Krier; Carolina Amador Carrascal; James F Greenleaf; Behzad Ebrahimi; Ahmad F Hedayat; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  J Am Soc Nephrol       Date:  2016-06-13       Impact factor: 10.121

7.  Adjunctive mesenchymal stem/stromal cells augment microvascular function in poststenotic kidneys treated with low-energy shockwave therapy.

Authors:  Xiao-Jun Chen; Xin Zhang; Kai Jiang; James D Krier; Xiangyang Zhu; Sabena Conley; Amir Lerman; Lilach O Lerman
Journal:  J Cell Physiol       Date:  2020-05-19       Impact factor: 6.384

8.  Persistent kidney dysfunction in swine renal artery stenosis correlates with outer cortical microvascular remodeling.

Authors:  Alfonso Eirin; Xiang-Yang Zhu; Victor H Urbieta-Caceres; Joseph P Grande; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Am J Physiol Renal Physiol       Date:  2011-03-02

9.  Protective Effects of Hydrocortisone, Vitamin C and E Alone or in Combination against Renal Ischemia-Reperfusion Injury in Rat.

Authors:  Omid Azari; Reza Kheirandish; Shahrzad Azizi; Mohammad Farajli Abbasi; Shahin Ghahramani Gareh Chaman; Masoud Bidi
Journal:  Iran J Pathol       Date:  2015

10.  Changes in glomerular filtration rate after renal revascularization correlate with microvascular hemodynamics and inflammation in Swine renal artery stenosis.

Authors:  Alfonso Eirin; Behzad Ebrahimi; Xin Zhang; Xiang-Yang Zhu; Hui Tang; John A Crane; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Circ Cardiovasc Interv       Date:  2012-10-09       Impact factor: 6.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.